HitGen (成都先导药物开发股份有限公司) is a biotech company providing a platform for small molecule drug discovery research. It focuses on the design, synthesis, and screening of DNA-encoded chemical libraries (DELs). The company specializes in a range of therapeutic areas, including oncology, cardiovascular, respiratory, metabolism, and other diseases.